- Aug 21, 2003
Vaccine makers have designed and tested a number of versions which show better efficacy against Omicron but nobody is beating down the FDA's door until they decide on a vaccination strategy. The Europeans are already contracting for multivalent vaccines to cover them in the fall.Yes, that would be nice. But the FDA cannot approve anything that hasn't yet been submitted for approval. That is like me asking you to approve my next request that I publicly make here for you. Will you do that?
Omicron specific vaccines should be submitted to the FDA around September, give or take a month.